We analyzed PRKD1 expression across bladder cancer (BLCA), kidney chromophobe (KICH), and rectal adenocarcinoma (READ) using data from the Gene Expression Omnibus (GEO) to validate our previous results. This evidence concerns the gene PRKD1 and urinary bladder cancer.